ExpreS2ion Biotech Holding AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 04/15/2024
ExpreS2ion Biotech Holding AB (publ) Stock Forecast and Price Target
According to esteemed experts, the average price target for ExpreS2ion Biotech Holding AB (publ) to reach this year is kr9.00, with a potential upside of approximately 328.57%. This prediction is based on a high estimate of kr9.00 and a low estimate of kr9.00.
328.57% Upside
ExpreS2ion Biotech Holding AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, ExpreS2ion Biotech Holding AB (publ)'s Price has grown by 100.00%, rising from kr0.00 to kr0.00. For the next year, analysts predict that Fair Value will reach kr0.00 – an increase of 100.00%. Over the next six years, experts believe that ExpreS2ion Biotech Holding AB (publ)'s Fair Value will grow at a rate of 100.00%.
ExpreS2ion Biotech Holding AB (publ) Revenue Forecast for 2023 - 2025 - 2030
In the last two years, ExpreS2ion Biotech Holding AB (publ) has seen a decline in its Revenue, from kr15.26M to kr6.15M – a 59.70% decrease. For the next year, analysts predict that Revenue will reach kr11.43M – an increase of 85.88%. Over the next eight years, experts believe that ExpreS2ion Biotech Holding AB (publ)'s Revenue will grow at a rate of 130.27%.
.jpg)
ExpreS2ion Biotech Holding AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
ExpreS2ion Biotech Holding AB (publ)'s EBITDA has seen growth In the last two years, going from kr-28.28M to kr-126.35M – a gain of 346.78% In the following year, 0 experts forecast ExpreS2ion Biotech Holding AB (publ)'s EBITDA will decrease by 55.20%, to kr-56.60M. In 2030, professionals predict that ExpreS2ion Biotech Holding AB (publ)'s EBITDA will decrease by 35.54%, to kr-81.45M.
ExpreS2ion Biotech Holding AB (publ) EBIT Forecast for 2023 - 2025 - 2030
In the last two years, EBIT for ExpreS2ion Biotech Holding AB (publ) has grown by 309.01%, going from kr-31.20M to kr-127.61M. According to 0 major analysts, ExpreS2ion Biotech Holding AB (publ)'s EBIT will fall by 53.23% in the next year, reaching kr-59.69M. Professionals believe that By 2030, ExpreS2ion Biotech Holding AB (publ)'s EBIT will fall to kr-82.53M– a 35.32% decrease from its current value.
ExpreS2ion Biotech Holding AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, ExpreS2ion Biotech Holding AB (publ)'s EPS has grown by 100.00%, rising from kr-1.50 to kr0.00. For the next year, analysts predict that EPS will reach kr0.00 – an increase of 100.00%. Over the next six years, experts believe that ExpreS2ion Biotech Holding AB (publ)'s EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)